Category: ROOT

Epic’s Garden Plot adds new software for medical groups

Epic added two new software solutions to Garden Plot, its software service geared toward independent medical groups with 40 or more providers. 

Telehealth startup allegedly treated minors without parents’ consent

Telehealth startup Cerebral has been accused of prescribing minors prescriptions without the consent of their parents, The Wall Street Journal reported Sept. 29. 

VA working with Oracle Cerner on investigations into EHR outages

The Department of Veterans Affairs is working with Oracle Cerner to conduct investigations into a flaw with the EHR system that caused thousands of orders for specialty care, lab work and other services, and claims to an undisclosed location, FedScoop …

Pennsylvania practice adds New Jersey ASC, expands surgical team

Dermatology of Philadelphia expanded into New Jersey with an ASC in Marlton, ROI NJ reported Sept. 29.

10 states with the highest infant mortality rate

The infant mortality rate in the U.S. continues to fall, and in 2020 the nation reached a historic low of 5.42 deaths per 1,000 live births, according to a Sept. 29 analysis from U.S. News & World Report.

At $200, Illumina unveils world’s cheapest genome sequencing

Genetic sequencing company Illumina has unveiled a new machine it says can sequence the human genome for just $200, Wired reported Sept. 29.

Medical org presidents to Congress: Pass healthcare worker violence protection bill

Association of American Medical Colleges President and CEO David Skorton, MD, and National Academy of Medicine President Victor Dzau, MD, are urging more action to address violence against healthcare workers.

10 highest-paying cities for mid-career, late-career gastroenterologists

Dallas is the highest-paying U.S. city for mid-career (eight to 14 years) gastroenterologists, while Atlanta is the highest-paying city for late-career (22 to 28 years) gastroenterologists, based on data compiled from Medscape’s 2022 salary reporter.&n…

FDA approves ALS drug based on 1 phase 2 trial

Months after an FDA panel voted against Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug, a second panel reversed the decision in a surprise vote before the agency approved the controversial ALS treatment Sept. 29. 

5 Optum, SCA Health leaders to know

Here are five leaders to know from Optum and its subsidiary and ASC chain SCA Health, pulled from the companies’ websites: